DK1007097T3 - Formulation of stabilized cationic transfection agents / nucleic acid particles - Google Patents

Formulation of stabilized cationic transfection agents / nucleic acid particles

Info

Publication number
DK1007097T3
DK1007097T3 DK98906986T DK98906986T DK1007097T3 DK 1007097 T3 DK1007097 T3 DK 1007097T3 DK 98906986 T DK98906986 T DK 98906986T DK 98906986 T DK98906986 T DK 98906986T DK 1007097 T3 DK1007097 T3 DK 1007097T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
DK98906986T
Other languages
Danish (da)
Inventor
Bruno Pitard
Joel Crouzet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1007097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1007097T3 publication Critical patent/DK1007097T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention concerns a composition containing stabilised particles of cationic transfection agent(s)/nucleic acid complexes characterised in that it includes besides said transfection agent and nucleic acid at least a non-ionic surfactant in sufficient amount for preventing the aggregation of the particles in course of time. In a preferred embodiment, the surfactant is a polyoxyalkylene or a derivative thereof.
DK98906986T 1997-02-10 1998-02-06 Formulation of stabilized cationic transfection agents / nucleic acid particles DK1007097T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (en) 1997-02-10 1997-02-10 FORMULATION OF CATIONIC TRANSFECTING AGENT (S) / NUCLEIC ACID PARTICLES
PCT/FR1998/000222 WO1998034648A1 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles

Publications (1)

Publication Number Publication Date
DK1007097T3 true DK1007097T3 (en) 2002-02-11

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906986T DK1007097T3 (en) 1997-02-10 1998-02-06 Formulation of stabilized cationic transfection agents / nucleic acid particles

Country Status (20)

Country Link
EP (1) EP1007097B1 (en)
JP (1) JP2001511171A (en)
KR (1) KR20000070914A (en)
AT (1) ATE206932T1 (en)
AU (1) AU737720B2 (en)
BR (1) BR9807563A (en)
CA (1) CA2278665A1 (en)
CZ (1) CZ282199A3 (en)
DE (1) DE69802102T2 (en)
DK (1) DK1007097T3 (en)
ES (1) ES2166146T3 (en)
FR (1) FR2759298B1 (en)
GR (1) GR3036919T3 (en)
HU (1) HUP0001720A3 (en)
IL (1) IL130765A0 (en)
NO (1) NO993825L (en)
PT (1) PT1007097E (en)
SK (1) SK282685B6 (en)
WO (1) WO1998034648A1 (en)
ZA (1) ZA981034B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
AU768542C (en) * 1998-04-08 2004-06-17 Celltech R & D Limited Lipids
WO2000003683A2 (en) * 1998-07-20 2000-01-27 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
BR0108959A (en) * 2000-03-03 2003-10-14 Valentis Inc Improved poloxamer or poloxamine compositions for nucleic acid delivery
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
ATE503463T1 (en) * 2000-10-20 2011-04-15 Vical Inc GENE DELIVERY FORMULATIONS FOR TREATING ISCHEMIC CONDITIONS
EP1232758A1 (en) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucleotide formulated for improved intracellular transfer
CA3031270A1 (en) 2004-03-03 2005-12-22 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1861112A4 (en) 2005-03-03 2009-07-22 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP4653242B1 (en) 2010-02-12 2011-03-16 ナノキャリア株式会社 Particulate pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
WO1996030051A1 (en) * 1995-03-31 1996-10-03 Genetic Therapy, Inc. Use of surfactants for introducing genetic material into lung cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
AU737720B2 (en) 2001-08-30
EP1007097A1 (en) 2000-06-14
EP1007097B1 (en) 2001-10-17
HUP0001720A1 (en) 2000-09-28
CZ282199A3 (en) 1999-10-13
JP2001511171A (en) 2001-08-07
ATE206932T1 (en) 2001-11-15
KR20000070914A (en) 2000-11-25
IL130765A0 (en) 2001-01-28
BR9807563A (en) 2000-02-01
ES2166146T3 (en) 2002-04-01
DE69802102T2 (en) 2002-03-14
HUP0001720A3 (en) 2001-10-29
FR2759298B1 (en) 1999-04-09
NO993825D0 (en) 1999-08-09
SK108299A3 (en) 2000-05-16
WO1998034648A1 (en) 1998-08-13
ZA981034B (en) 1998-08-11
GR3036919T3 (en) 2002-01-31
AU6298798A (en) 1998-08-26
DE69802102D1 (en) 2001-11-22
PT1007097E (en) 2002-04-29
FR2759298A1 (en) 1998-08-14
CA2278665A1 (en) 1998-08-13
SK282685B6 (en) 2002-11-06
NO993825L (en) 1999-08-09

Similar Documents

Publication Publication Date Title
DK1007097T3 (en) Formulation of stabilized cationic transfection agents / nucleic acid particles
ATE383169T1 (en) COMPONENT AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
FR2791895B1 (en) USE OF TREHALOSE TO STABILIZE A LIQUID VACCINE
PT1123120E (en) MEDICINAL FORMULATION IN AEROSOL
TR199501321A2 (en) Pharmaceutical compositions.
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
HUP0202501A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
DE60003943D1 (en) TRIMEGESTONE CONTAINING PHARMACEUTICAL COMPOSITIONS
MXPA04001007A (en) Invert emulsion containing dhea.
ATE174955T1 (en) STABLE, NON-IONIC SURFACTANT EMULSIONS CONTAINING VISCOSITY CONTROL AGENTS
ES2179508T3 (en) COSMETIC COMPOSITION THAT INCLUDES AN AMIDA AND NEW AMIDAS.
EP1003606A4 (en) Alkylpolyglycoside containing surfactant blends for emulsion polymerization
TR199801460T2 (en) Cleansing composition containing color stabilizer(s) and surfactant(s).
BR9811985A (en) Dosing device
DE69429252T2 (en) LIQUID MEDICINAL COMPOSITIONS CONTAINING IBUPROFEN
EP1385948A4 (en) Nucleic acids for inhibiting hairless protein expression and methods of use thereof
BR9910549B1 (en) stabilized compositions, process for stabilizing quaternary ammonium material, and use of a stabilizing agent.
HUP0202378A3 (en) Surfactant mixture, emulsion containing thereof structured surfactant composition and detergent composition
WO1999055634A8 (en) Superfluidifying additive for cementitious compositions
ATE310075T1 (en) CLEANING AGENT COMPONENT WITH FINE PARTICLE SOLIDS
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid